Systemic adjuvant therapy for breast cancer.

  title={Systemic adjuvant therapy for breast cancer.},
  author={Clifford A. Hudis and Larry Norton},
  journal={Current opinion in oncology},
  volume={5 6},
The use of systemic (drug) therapy postoperatively reduces the risk of relapse and death for patients with resectable invasive breast cancer. The Early Breast Cancer Trialists' Collaborative Group overview analysis confirmed the benefits of both polychemotherapy and tamoxifen in broad subgroups of patients. It remains a challenge, however, to quantify the… CONTINUE READING